Exelixis
EXEL
#1683
Rank
โ‚ฌ9.70 B
Marketcap
33,98ย โ‚ฌ
Share price
1.51%
Change (1 day)
74.85%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company